431 results on '"Jansen, Marnix"'
Search Results
2. 223 IMMUNE CELL PHENOTYPING IN BARRETT'S ESOPHAGUS IN PATIENTS PRIOR AND AT TIME OF PROGRESSION
3. Deep Learning for Histopathological Assessment of Esophageal Adenocarcinoma Precursor Lesions
4. Poor Diagnostic Reproducibility in the Identification of Nonconventional Dysplasia in Colitis Impacts the Application of Histologic Stratification Tools
5. The Tissue Systems Pathology Test Outperforms Pathology Review in Risk Stratifying Patients With Low-Grade Dysplasia
6. The co-evolution of the genome and epigenome in colorectal cancer
7. Phenotypic plasticity and genetic control in colorectal cancer evolution
8. Hepatocytes undergo punctuated expansion dynamics from a periportal stem cell niche in normal human liver
9. NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumour mutation burden for high risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer.
10. Multi-scale Deformable Transformer for the Classification of Gastric Glands: The IMGL Dataset
11. Epigenome and early selection determine the tumour-immune evolutionary trajectory of colorectal cancer
12. Immunosuppressive niche engineering at the onset of human colorectal cancer
13. Phase 0 Study of Vandetanib-Eluting Radiopaque Embolics as a Preoperative Embolization Treatment in Patients with Resectable Liver Malignancies
14. Study on intracranial meningioma using PET ligand investigation during follow-up over years (SIMPLIFY)
15. Multi-scale Deformable Transformer for the Classification of Gastric Glands: The IMGL Dataset
16. Poor diagnostic reproducibility in the identification of non-conventional dysplasia in colitis impacts the application of histological stratification tools
17. The complexity of cancer origins at the gastro-oesophageal junction
18. Evidence for hypoxia increasing the tempo of evolution in glioblastoma
19. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
20. 300. ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ESOPHAGEAL ADENOCARCINOMA: PRELIMINARY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
21. Comparison of two multiband mucosectomy devices for endoscopic resection of Barrett’s esophagus-related neoplasia
22. A Probabilistic Model Combining Deep Learning and Multi-atlas Segmentation for Semi-automated Labelling of Histology
23. The Japanese Viewpoint on the Histopathology of Early Gastric Cancer
24. What Makes an Expert Barrett’s Histopathologist?
25. Distal Esophageal Adenocarcinoma and Gastric Adenocarcinoma: Time for a Shared Research Agenda
26. The Role of Serum S100B as a Clinical Follow-up Tool for Disease Recurrence in Stage III Melanoma Patients
27. Evolutionary and immune microenvironment dynamics during neoadjuvant treatment of oesophagael adenocarcinoma
28. Abstract 4539: Tumor evolution and immune microenvironment dynamics define response to neoadjuvant treatment of esophageal adenocarcinoma
29. Figure S2 from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
30. Supplemental methods and tables from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
31. Supplementary Information from Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry
32. The metaplastic mosaic of Barrett’s oesophagus
33. A digital pathology workflow for the segmentation and classification of gastric glands: Study of gastric atrophy and intestinal metaplasia cases
34. A Probabilistic Model Combining Deep Learning and Multi-atlas Segmentation for Semi-automated Labelling of Histology
35. The Barrett’s Gland in Phenotype Space
36. Gland segmentation in gastric histology images: detection of intestinal metaplasia
37. Analysis of metastases rates during follow-up after endoscopic resection of early “high-risk” esophageal adenocarcinoma
38. The Need for Routine Native Nephrectomy in the Workup for Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients
39. ENDOSCOPIC FOLLOW-UP OF RADICALLY RESECTED SUBMUCOSAL ADENOCARCINOMA IN BARRETT’S ESOPHAGUS: EARLY RESULTS OF AN ONGOING PROSPECTIVE, INTERNATIONAL, MULTICENTER COHORT REGISTRY (PREFER TRIAL)
40. P110 Cytosponge for risk stratification in patients with Barrett’s oesophagus overdue endoscopic surveillance due to COVID-19
41. NEOPRISM-CRC: Neoadjuvant pembrolizumab stratified to tumor mutation burden for high-risk stage 2 or stage 3 deficient-MMR/MSI-high colorectal cancer.
42. Mo1164: UTILISATION OF THE CYTOSPONGE DEVICE AS A TOOL FOR RISK STRATIFICATION IN PATIENTS WITH BARRETT'S OESOPHAGUS WHO ARE OVERDUE ENDOSCOPIC SURVEILLANCE DUE TO THE COVID-19 PANDEMIC
43. Analysis of clonal expansions through the normal and premalignant human breast epithelium reveals the presence of luminal stem cells
44. The Need for Routine Native Nephrectomy in the Workup for Kidney Transplantation in Autosomal Dominant Polycystic Kidney Disease Patients.
45. Pan-cancer analysis of the extent and consequences of intratumor heterogeneity
46. Clonal Transitions and Phenotypic Evolution in Barrett’s Esophagus
47. Histopathology-led quality evaluation of endoluminal excision specimens – not a bad idea!
48. Three-dimensional tumour microenvironment reconstruction and tumour-immune interactions' analysis
49. HFR-1 Cytosponge as a risk stratification tool in patients overdue barrett’s surveillance due to Covid-19
50. Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.